Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
72,649.41
(
-0.45%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

md1225

Send PM Follow Ignore
Followers 98
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

md1225

Re: EYEBUYSTOX post# 205613

Saturday, 02/07/2015 7:34:12 PM

Saturday, February 07, 2015 7:34:12 PM

Post# of 347009
The increase in size of Avid capacity is for the potential launch of bavituximab.

The FDA "will not halt the trial" unless Peregrine has the capacity to produce bavituximab with commercialization possible.

It will be possible by 7/15.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote